Fairfax Station, VA, United States of America

Zhiyong Han

This inventor holds 1 USPTO granted patent. Top assignee: The George Washington University. Active years: 2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Zhiyong Han. Retrieved from https://idiyas.com/inventor/zhiyong-han

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2021

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Zhiyong Han: Innovator in Cancer Treatment

Introduction

Zhiyong Han is a notable inventor based in Fairfax Station, VA (US). He has made significant contributions to the field of cancer treatment through his innovative research and patent work. His dedication to improving therapeutic options for patients is evident in his patented inventions.

Latest Patents

Zhiyong Han holds a patent for 4,4'-trans-dihydroxystilbene, which is utilized in treating cancer. The patent outlines methods, pharmaceutical compositions, dosing regimens, and kits that incorporate 4,4'-trans-dihydroxystilbene (DHS). This invention includes methods for treating cancer in a subject and strategies for decreasing or reversing resistance to DNA damaging agents in patients.

Career Highlights

Zhiyong Han is affiliated with The George Washington University, where he continues to engage in research and development in the field of oncology. His work has garnered attention for its potential impact on cancer therapies.

Collaborations

Zhiyong Han has collaborated with esteemed colleagues, including Wenge Zhu and Chi-Wei Chen. Their combined expertise contributes to the advancement of cancer treatment methodologies.

Conclusion

Zhiyong Han's innovative work in cancer treatment exemplifies the importance of research and development in the medical field. His contributions through patents and collaborations highlight his commitment to improving patient outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…